1029 related articles for article (PubMed ID: 9499426)
1. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
[TBL] [Abstract][Full Text] [Related]
2. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
Wilschanski M; Zielenski J; Markiewicz D; Tsui LC; Corey M; Levison H; Durie PR
J Pediatr; 1995 Nov; 127(5):705-10. PubMed ID: 7472820
[TBL] [Abstract][Full Text] [Related]
3. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
[TBL] [Abstract][Full Text] [Related]
4. Isolated elevated sweat chloride concentrations in the presence of the rare mutation S1455X: an extremely mild form of CFTR dysfunction.
Salvatore D; Tomaiuolo R; Vanacore B; Elce A; Castaldo G; Salvatore F
Am J Med Genet A; 2005 Mar; 133A(2):207-8. PubMed ID: 15666307
[TBL] [Abstract][Full Text] [Related]
5. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
Highsmith WE; Burch LH; Zhou Z; Olsen JC; Boat TE; Spock A; Gorvoy JD; Quittel L; Friedman KJ; Silverman LM
N Engl J Med; 1994 Oct; 331(15):974-80. PubMed ID: 7521937
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
[TBL] [Abstract][Full Text] [Related]
8. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.
Fulmer SB; Schwiebert EM; Morales MM; Guggino WB; Cutting GR
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6832-6. PubMed ID: 7542778
[TBL] [Abstract][Full Text] [Related]
9. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
Yeh JT; Yu YC; Hwang TC
J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
[TBL] [Abstract][Full Text] [Related]
10. Loss of carbonic anhydrase XII function in individuals with elevated sweat chloride concentration and pulmonary airway disease.
Lee M; Vecchio-Pagán B; Sharma N; Waheed A; Li X; Raraigh KS; Robbins S; Han ST; Franca AL; Pellicore MJ; Evans TA; Arcara KM; Nguyen H; Luan S; Belchis D; Hertecant J; Zabner J; Sly WS; Cutting GR
Hum Mol Genet; 2016 May; 25(10):1923-1933. PubMed ID: 26911677
[TBL] [Abstract][Full Text] [Related]
11. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
12. Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results.
Desmarquest P; Feldmann D; Tamalat A; Boule M; Fauroux B; Tournier G; Clement A
Chest; 2000 Dec; 118(6):1591-7. PubMed ID: 11115444
[TBL] [Abstract][Full Text] [Related]
13. Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens.
Radpour R; Gourabi H; Gilani MA; Dizaj AV; Rezaee M; Mollamohamadi S
Mol Hum Reprod; 2006 Nov; 12(11):717-21. PubMed ID: 16973827
[TBL] [Abstract][Full Text] [Related]
14. Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.
Durmowicz AG; Witzmann KA; Rosebraugh CJ; Chowdhury BA
Chest; 2013 Jan; 143(1):14-18. PubMed ID: 23276841
[TBL] [Abstract][Full Text] [Related]
15. [Cystic fibrosis and normal sweat chloride values: a case-report].
Lebecque P; Leal T; Godding V
Rev Mal Respir; 2001 Sep; 18(4 Pt 1):443-5. PubMed ID: 11547256
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
17. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.
Mickle JE; Milewski MI; Macek M; Cutting GR
Am J Hum Genet; 2000 May; 66(5):1485-95. PubMed ID: 10762539
[TBL] [Abstract][Full Text] [Related]
18. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
[TBL] [Abstract][Full Text] [Related]
19. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
[TBL] [Abstract][Full Text] [Related]
20. Mutations in CFTR gene and clinical correlation in Argentine patients with congenital bilateral absence of the vas deferens.
Levy EM; Granados P; Rawe V; Olmedo SB; Luna MC; Cafferata E; Pivetta OH
Medicina (B Aires); 2004; 64(3):213-8. PubMed ID: 15239534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
